# Build a weekly portfolio review Canonical URL: https://biopharmsignal.com/use-cases/long-term-biotech-investors/build-a-weekly-portfolio-review Role: [Long-Term Biotech Investors](https://biopharmsignal.com/use-cases/long-term-biotech-investors.md) Category: Efficient portfolio monitoring Last updated: 2026-07-26 Summarize material changes, future milestones, and required actions. ## The Situation A long-term biotech investor wants a consistent review habit that captures material events without requiring continuous market monitoring. ### Best Fit Individual and professional investors who hold biotech positions across multi-quarter or multi-year development cycles. ## The Challenge Summarize material changes, future milestones, and required actions. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task A long-term biotech investor wants a consistent review habit that captures material events without requiring continuous market monitoring. For long-term investors, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Summarize material changes, future milestones, and required actions. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Build a weekly portfolio review” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes material events from the prior week, upcoming milestones, thesis and guidance changes, cash and financing risk, watchlist cleanup. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output A weekly portfolio page listing what changed, what requires research, what remains on schedule, and which alerts or watchlist entries need adjustment. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The investor maintains a current thesis record in a bounded weekly process instead of rebuilding context after every major event. ## Illustrative Example ### Illustrative workflow: build a weekly portfolio review Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in material events from the prior week, and why does it matter? - What has changed in upcoming milestones, and why does it matter? - What has changed in thesis and guidance changes, and why does it matter? - What has changed in cash and financing risk, and why does it matter? - What has changed in watchlist cleanup, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “build a weekly portfolio review.” 2. Set the monitored scope around material events from the prior week and upcoming milestones. 3. Collect source-linked updates for thesis and guidance changes and record what changed from the prior state. 4. Review cash and financing risk together with watchlist cleanup before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - Material events from the prior week - Upcoming milestones - Thesis and guidance changes - Cash and financing risk - Watchlist cleanup ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable A weekly portfolio page listing what changed, what requires research, what remains on schedule, and which alerts or watchlist entries need adjustment. ## Practical Outcome The investor maintains a current thesis record in a bounded weekly process instead of rebuilding context after every major event. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for long-term biotech investors and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? A weekly portfolio page listing what changed, what requires research, what remains on schedule, and which alerts or watchlist entries need adjustment. ### What is the practical benefit? The investor maintains a current thesis record in a bounded weekly process instead of rebuilding context after every major event. ## Related Workflows - [How Long-Term Biotech Investors Monitor a Portfolio in Limited Time](https://biopharmsignal.com/use-cases/long-term-biotech-investors/monitor-biotech-portfolio-with-limited-time.md) - [How to Detect Thesis-Changing Events in a Biotech Portfolio](https://biopharmsignal.com/use-cases/long-term-biotech-investors/detect-thesis-changing-biotech-events.md) - [How Long-Term Investors Track Biotech Cash Runway and Financing Risk](https://biopharmsignal.com/use-cases/long-term-biotech-investors/track-biotech-cash-runway-and-financing.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.